Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders

The New England Journal of Medicine
L SideKevin M Shannon

Abstract

The risk of malignant myeloid disorders in young children with neurofibromatosis type 1 is 200 to 500 times the normal risk. The gene for neurofibromatosis type 1 (NF1) encodes neurofibromin, a protein that negatively regulates signals transduced by Ras proteins. Genetic and biochemical data support the hypothesis that NF1 functions as a tumor-suppressor gene in immature myeloid cells, but inactivation of both NF1 alleles has not been demonstrated in leukemic cells from patients with neurofibromatosis type 1. Using an in vitro transcription and translation system, we screened bone marrow samples from 18 children with neurofibromatosis type 1 and myeloid disorders for NF1 mutations that cause a truncated protein. Mutations were confirmed by direct sequencing of genomic DNA from the patients, and from their affected parents, in cases of familial neurofibromatosis type 1. Specimens from 9 of the 18 children contained abnormal peptide fragments, and truncating mutations of the NF1 gene were found in specimens from 8 of these children. The normal NF1 allele was absent in bone marrow samples from five of the eight children. We detected the same mutation in DNA from the affected parent of each child with familial neurofibromatosis typ...Continue Reading

References

Nov 22, 1991·Science·R A Weinberg
Jan 1, 1991·Genes, Chromosomes & Cancer·T W GloverS Johnson
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A G MenonF P Li
Jun 1, 1995·Human Molecular Genetics·R A HeimM C Luce
Nov 1, 1994·Nature Genetics·R A HeimM C Luce
Jul 1, 1994·Nature Genetics·T JacksR A Weinberg
Nov 1, 1994·British Journal of Cancer·C A StillerM Fitchett
Dec 30, 1993·The New England Journal of Medicine·S M PowellK W Kinzler
Dec 16, 1993·Nature·M S Boguski, F McCormick
Jan 1, 1993·Nature Genetics·I TheA Bernards
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M R JohnsonD R Lowy
Jan 18, 1996·The New England Journal of Medicine·M G FitzGeraldD A Haber
Sep 1, 1996·Nature Genetics·S SawadaD Viskochil
Nov 1, 1996·Molecular Medicine Today·P D EmanuelR P Castleberry

❮ Previous
Next ❯

Citations

Aug 16, 2001·International Journal of Hematology·Pierre Fenaux
Nov 15, 2002·International Journal of Hematology·Hisamaru Hirai
Feb 2, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Marica EoliGaetano Finocchiaro
Apr 30, 2003·Current Treatment Options in Oncology·Charlotte Marie Niemeyer, Christian Kratz
Apr 8, 2009·Current Neurology and Neuroscience Reports·Kaleb Yohay
Oct 3, 2003·Current Oncology Reports·Charlotte Marie Niemeyer, Christian Kratz
Oct 21, 2004·Best Practice & Research. Clinical Haematology·Ghulam J Mufti
Mar 31, 2005·Pediatric Neurology·Beth Ann Ward, David H Gutmann
Sep 21, 2000·Leukemia Research·O AfonjaK Takeshita
Jan 16, 2003·Leukemia Research·David P Steensma, Ayalew Tefferi
Jul 21, 1998·Leukemia Research·C Mecucci
Sep 28, 1998·Biochimica Et Biophysica Acta·C A Felix
May 9, 2001·Biochimica Et Biophysica Acta·A I McClatchey, K Cichowski
Apr 19, 2002·Biochimica Et Biophysica Acta·Shane DonovanGideon Bollag
Apr 5, 2001·Trends in Molecular Medicine·N Reed, D H Gutmann
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 14, 2013·Nature Reviews. Clinical Oncology·Andrew L Lin, David H Gutmann
Oct 16, 2007·Oncogene·R A Van Etten
Oct 16, 1999·British Journal of Haematology·J MiyauchiS Mizutani
Aug 10, 2000·Neuropathology and Applied Neurobiology·D H GutmannA Perry
May 29, 2002·International Journal of Dermatology·Pètra BraamMarijke R Canninga-Van Dijk
Jun 10, 1998·The Journal of Experimental Medicine·Y Y ZhangD W Clapp
Jan 4, 1998·Journal of Pediatric Hematology/oncology·A S O'Marcaigh, K M Shannon
Apr 8, 2003·Journal of Pediatric Hematology/oncology·Christian P KratzSarah E Friebert
Apr 17, 2004·Journal of Pediatric Hematology/oncology·Yu-Hsiang ChangKai-Hsin Lin
Dec 17, 2003·Current Opinion in Hematology·Marco TartagliaMignon L Loh
Jun 24, 2010·Current Opinion in Hematology·Karl StaserDavid W Clapp
Nov 11, 1999·British Journal of Haematology·P D Emanuel
Sep 14, 2012·Epilepsia·Aine MerwickNorman Delanty
Nov 28, 2007·Annual Review of Pathology·Andrea I McClatchey
May 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Brian ParkinSami N Malek
Jul 1, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ann Mullally, Benjamin L Ebert
Aug 15, 2006·The Journal of Clinical Investigation·Fraz A IsmatJonathan A Epstein
Dec 12, 2012·The Journal of Clinical Investigation·Tiffany ChangKevin Shannon
Dec 12, 2012·The Journal of Clinical Investigation·Karl StaserD Wade Clapp
Jul 23, 2011·Genes & Cancer·Esther Castellano, Julian Downward

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.